Description
The market report provided a comprehensive analysis segmented by Product & Service (Assay Kits, Instruments, Services); by Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring); by Circulating Biomarker (Circulating Tumor Cells, Cell-free DNA, Circulating Cell-Free RNA, Exosomes and Extracellular Vesicles, Others); by End User (Reference Laboratories, Hospital and Physician Laboratories, Academic & Research Centers, Others); by Geography (North America, South America, Asia Pacific, Europe, The Middle East, Africa).
Additional information
| Plans | Single User License, Five User License, Enterprise License |
|---|
